Baird Medical Investment Holdings Limited
BDMD
$3.14
$0.051.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 37.04M | 35.04M | 33.05M | 32.25M | 31.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.04M | 35.04M | 33.05M | 32.25M | 31.46M |
| Cost of Revenue | 4.38M | 4.11M | 3.83M | 4.03M | 4.23M |
| Gross Profit | 32.65M | 30.94M | 29.22M | 28.22M | 27.23M |
| SG&A Expenses | 11.16M | 11.20M | 11.25M | 11.17M | 11.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.72M | 20.41M | 19.09M | 19.34M | 19.60M |
| Operating Income | 15.32M | 14.64M | 13.96M | 12.91M | 11.86M |
| Income Before Tax | 14.09M | 14.18M | 14.28M | 13.32M | 12.36M |
| Income Tax Expenses | 1.49M | 1.54M | 1.60M | 1.65M | 1.70M |
| Earnings from Continuing Operations | 12.60 | 12.64 | 12.68 | 11.67 | 10.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -144.60K | -138.50K | -132.40K | -122.30K | -112.20K |
| Net Income | 12.45M | 12.50M | 12.55M | 11.55M | 10.55M |
| EBIT | 15.32M | 14.64M | 13.96M | 12.91M | 11.86M |
| EBITDA | 16.45M | 15.80M | 15.15M | 14.01M | 12.88M |
| EPS Basic | 0.52 | 0.52 | 0.53 | 0.49 | 0.46 |
| Normalized Basic EPS | 0.36 | 0.37 | 0.37 | 0.35 | 0.33 |
| EPS Diluted | 0.52 | 0.52 | 0.52 | 0.49 | 0.45 |
| Normalized Diluted EPS | 0.36 | 0.37 | 0.37 | 0.35 | 0.33 |
| Average Basic Shares Outstanding | 102.22M | 102.22M | 102.22M | 102.22M | 102.22M |
| Average Diluted Shares Outstanding | 102.51M | 102.37M | 102.22M | 102.22M | 102.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |